We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current BPTH market cap is 1.87M. The company's latest EPS is USD -23.6861 and P/E is -0.12.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.55M | -4.48M | -5.29M | -4.24M | -3.28M |
| Net Income | -3.54M | -3.97M | -5.27M | -4.23M | -3.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 10.44M | 0 | 0 |
| Operating Income | -8.69M | -10.91M | 0 | -13.9M | -15.84M |
| Net Income | -8.6M | -10.88M | 21.65M | -13.87M | -16.08M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 18.54M | 15.97M | 11.1M | 6.52M | 5.02M |
| Total Liabilities | 2.34M | 1.8M | 2M | 1.48M | 2.5M |
| Total Equity | 16.2M | 14.17M | 9.11M | 5.04M | 2.53M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 22.66M | 16.48M | 26.57M | 15.97M | 3.22M |
| Total Liabilities | 1.57M | 1.41M | 1.11M | 1.8M | 2.78M |
| Total Equity | 21.09M | 15.07M | 25.46M | 14.17M | 441k |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.1M | -15.1M | -3.65M | -6.94M | -9.72M |
| Investing | -21k | -21k | N/A | N/A | N/A |
| Financing | N/A | 1.73M | N/A | N/A | 1.69M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.36M | -10.96M | -9.92M | -15.1M | -11.54M |
| Investing | N/A | N/A | -70k | -21k | N/A |
| Financing | 27.78M | 4.29M | 20.01M | 1.73M | 2.2M |
| Market Cap | 1.87M |
| Price to Earnings Ratio | -0.12 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.79 |
| Price to Book Ratio | 4.26 |
| Dividend Yield | - |
| Shares Outstanding | 678.8k |
| Average Volume (1 week) | 116.41k |
| Average Volume (1 Month) | 4.39M |
| 52 Week Change | -90.00% |
| 52 Week High | 44.80 |
| 52 Week Low | 2.3601 |
| Spread (Intraday) | 0.1 (3.5%) |
| Company Name | Bio Path Holdings Inc |
| Address |
108 lakeland ave dover, delaware 19901 |
| Website | https://www.biopathholdings.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
